Obesity in pregnancy—Long‐term effects on offspring hypothalamic‐pituitary‐adrenal axis and associations with placental cortisol metabolism: A systematic review
European Journal of Neuroscience · 2023-12 · 58 (11) · 4393-4422
DOI: 10.1111/ejn.16184 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Neuroscience, online erschienen am 16.11.2023. Verfasst von Tabia Volqvartz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Hauptthemen laut MEDLINE: Pregnancy in Obesity, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Aarhus University., Aarhus Universitet.
Abstract (Originalsprache)
Obesity, affecting one in three pregnant women worldwide, is not only a major obstetric risk factor. The resulting low‐grade inflammation may have a long‐term impact on the offspring's HPA axis through dysregulation of maternal, placental and fetal corticosteroid metabolism, and children born of obese mothers have increased risk of diabetes and cardiovascular disease. The long‐term effects of maternal obesity on offspring neurodevelopment are, however, undetermined and could depend on the specific effects on placental and fetal cortisol metabolism. This systematic review evaluates how maternal obesity affects placental cortisol metabolism and the offspring's HPA axis. Pubmed, Embase and Scopus were searched for original studies on maternal BMI, obesity, and cortisol metabolism and transfer. Fifteen studies were included after the screening of 4556 identified records. Studies were small with heterogeneous exposures and outcomes. Two studies found that maternal obesity reduced placental HSD11β2 activity. In one study, umbilical cord blood cortisol levels were affected by maternal BMI. In three studies, an altered cortisol response was consistently seen among offspring in childhood ( n = 2) or adulthood ( n = 1). Maternal BMI was not associated with placental HSD11β1 or HSD11β2 mRNA expression, or placental HSD11β2 methylation. In conclusion, high maternal BMI is associated with reduced placental HSD11β2 activity and a dampened cortisol level among offspring, but the data is sparse. Further investigations are needed to clarify whether the HPA axis is affected by prenatal factors including maternal obesity and investigate if adverse effects can be ameliorated by optimising the intrauterine environment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Biomedicine, Pharmacology, Aarhus University, Aarhus, Denmark.
- Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark.
ORCID-Profile: Tabia Volqvartz, Lars Henning Pedersen
Förderung
- Aarhus University.
- Aarhus Universitet
Zitieren
APA
Volqvartz, T., Andersen, H. H. B., Pedersen, L. H., & Larsen, A. (2023). Obesity in pregnancy—Long‐term effects on offspring hypothalamic‐pituitary‐adrenal axis and associations with placental cortisol metabolism: A systematic review. European Journal of Neuroscience, 58(11), 4393-4422. https://doi.org/10.1111/ejn.16184
Vancouver
Volqvartz T, Andersen HHB, Pedersen LH, Larsen A. Obesity in pregnancy—Long‐term effects on offspring hypothalamic‐pituitary‐adrenal axis and associations with placental cortisol metabolism: A systematic review. European Journal of Neuroscience. 2023;58(11):4393-4422. doi:10.1111/ejn.16184
BibTeX
@article{Volqvartz2023,
author = {Volqvartz, Tabia and Andersen, Helena Hørdum Breum and Pedersen, Lars Henning and Larsen, Agnete},
title = {Obesity in pregnancy—Long‐term effects on offspring hypothalamic‐pituitary‐adrenal axis and associations with placental cortisol metabolism: A systematic review},
journal = {European Journal of Neuroscience},
year = {2023},
volume = {58},
number = {11},
pages = {4393--4422},
doi = {10.1111/ejn.16184}
}
EUVIMED